The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(5-amino-3,4-dimethylthieno[2,3-c]pyridazin-6-yl)-3-(3-fluoro-4-methoxyphenyl)propan-1-one ID: ALA4531229
PubChem CID: 155546031
Max Phase: Preclinical
Molecular Formula: C18H18FN3O2S
Molecular Weight: 359.43
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(CCC(=O)c2sc3nnc(C)c(C)c3c2N)cc1F
Standard InChI: InChI=1S/C18H18FN3O2S/c1-9-10(2)21-22-18-15(9)16(20)17(25-18)13(23)6-4-11-5-7-14(24-3)12(19)8-11/h5,7-8H,4,6,20H2,1-3H3
Standard InChI Key: COXVTJZPOHPAAV-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
16.0895 -25.8181 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.7975 -26.2271 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.5044 -24.9950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5046 -25.8182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2876 -26.0723 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
18.7713 -25.4062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2872 -24.7404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5395 -23.9632 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.5885 -25.4059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9973 -26.1135 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.0906 -24.9986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7956 -24.5850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7930 -23.7678 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9969 -24.6981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8140 -24.6978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2224 -23.9899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0382 -23.9926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4465 -23.2856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0376 -22.5770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2162 -22.5799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8116 -23.2875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3818 -24.5920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4432 -21.8711 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.0334 -21.1641 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8048 -21.8738 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
11 1 2 0
1 2 1 0
2 4 2 0
3 12 2 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 2 0
7 3 1 0
7 8 1 0
6 9 1 0
9 10 2 0
11 12 1 0
12 13 1 0
9 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
11 22 1 0
23 24 1 0
19 23 1 0
20 25 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 359.43Molecular Weight (Monoisotopic): 359.1104AlogP: 3.85#Rotatable Bonds: 5Polar Surface Area: 78.10Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 1.17CX LogP: 3.44CX LogD: 3.44Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.70Np Likeness Score: -1.19
References 1. Wood MR, Noetzel MJ, Tarr JC, Rodriguez AL, Lamsal A, Chang S, Foster JJ, Smith E, Chase P, Hodder PS, Engers DW, Niswender CM, Brandon NJ, Wood MW, Duggan ME, Conn PJ, Bridges TM, Lindsley CW.. (2016) Discovery and SAR of a novel series of potent, CNS penetrant M4 PAMs based on a non-enolizable ketone core: Challenges in disposition., 26 (17): [PMID:27476142 ] [10.1016/j.bmcl.2016.07.042 ]